Edward Morrow Atkinson III, EVP, Chief Technical Operations Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 2,658 shares at $420.24 ($1.1M) on 2024-02-12, disclosed to the SEC on 2024-02-13.
Scheduled sale ($1.1M) by EVP, Chief Technical Operations Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $422.74 | 832 | $352K | 31.4% |
| 2 | $420.24 | 913 | $384K | 34.3% |
| 3 | $420.24 | 913 | $384K | 34.3% |
| Total | $421.02 avg | 2,658 | $1.1M | 100% |
| Filing → |
| VRTX | SELL | 2026-02-12 | $806K | — | Filing → |
| VRTX | SELL | 2025-11-19 | $1.1M | — | Filing → |
| VRTX | SELL | 2025-02-28 | $1.3M | — | Filing → |